ClinicalTrials.Veeva

Menu

Comparing the Use of Dienogest and Combined Oral Contraceptive Pills (Microgynon) to Reduce the Risk of Recurrence of Endometriotic Cyst After Conservative Surgery

The University of Hong Kong (HKU) logo

The University of Hong Kong (HKU)

Status and phase

Unknown
Phase 4

Conditions

Endometriosis

Treatments

Drug: Dienogest
Drug: Microgynon

Study type

Interventional

Funder types

Other

Identifiers

NCT02385448
UW 14-097

Details and patient eligibility

About

The purpose of the study is to compare the recurrence of endometriotic cyst in patients taking Dienogest or Microgynon after conservative surgery.

Enrollment

144 estimated patients

Sex

Female

Ages

18 to 51 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Good general health
  • Older than the age of legal consent (i.e. 18 years old)
  • Sonographic diagnosis of ovarian endometrioma with diameter at least 4cm on 2 separate scans at least 6 weeks apart
  • No contraindication to use of progesterone or combined oral contraceptive pills
  • Not attempting to conceive either at the time of study entry or for at least 2 years after surgery
  • Willing and able to participate after the study has been explained

Exclusion criteria

  • Operative findings not suggestive of endometriotic cyst
  • Contraindications to progestogens or oral contraceptive pills
  • Unwillingness to tolerate menstrual irregularity
  • Planning pregnancy within 2 years of study
  • Cannot understand English, Cantonese or Putonghua

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

144 participants in 2 patient groups

Dienogest
Experimental group
Treatment:
Drug: Dienogest
Combined oral contraceptive pills
Active Comparator group
Treatment:
Drug: Microgynon

Trial contacts and locations

1

Loading...

Central trial contact

Man Wa Lui, MBBS, MRCOG; Jennifer K.Y. Ko, MBBS, MRCOG

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems